Expression of Mesenchymal and α-Cell Phenotypic Markers in Islet β-Cells in Recently Diagnosed Diabetes
Open Access
- 15 October 2013
- journal article
- case report
- Published by American Diabetes Association in Diabetes Care
- Vol. 36 (11) , 3818-3820
Abstract
OBJECTIVE: Relative contributions of reversible β-cell dysfunction and true decrease in β-cell mass in type 2 diabetes remain unclear. Definitive rodent lineage-tracing studies have identified β-cell dedifferentiation and subsequent reprogramming to α-cell fate as a novel mechanism underlying β-cell failure. The aim was to determine whether phenotypes of β-cell dedifferentiation and plasticity are present in human diabetes. RESEARCH DESIGN AND METHODS: Immunofluorescence colocalization studies using classical endocrine and mesenchymal phenotypic markers were undertaken using pancreatic sections and isolated islets from three individuals with diabetes and five nondiabetic control subjects. RESULTS: Intraislet cytoplasmic coexpression of insulin and vimentin, insulin and glucagon, and vimentin and glucagon were demonstrated in all cases. These phenotypes were not present in nondiabetic control subjects. CONCLUSIONS: Coexpression of mesenchymal and α-cell phenotypic markers in human diabetic islet β-cells has been confirmed, providing circumstantial evidence for β-cell dedifferentiation and possible reprogramming to α-cells in clinical diabetes.Keywords
This publication has 10 references indexed in Scilit:
- Beta-Cell Dedifferentiation and Type 2 DiabetesNew England Journal of Medicine, 2013
- Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell FailureCell, 2012
- Insulin-Producing Cells Generated from Dedifferentiated Human Pancreatic Beta Cells Expanded In VitroPLOS ONE, 2011
- Longevity of human islet α ‐ and β ‐cellsDiabetes, Obesity and Metabolism, 2011
- Evidence for Epithelial-Mesenchymal Transition in Adult Human Pancreatic Exocrine CellsJournal of Histochemistry & Cytochemistry, 2010
- The replication of β cells in normal physiology, in disease and for therapyNature Clinical Practice Endocrinology & Metabolism, 2007
- The Role of α-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic ImplicationsEndocrine Reviews, 2007
- Epithelial-to-Mesenchymal Transition Generates Proliferative Human Islet Precursor CellsScience, 2004
- Lilly Lecture 2003Diabetes, 2004
- β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 DiabetesDiabetes, 2003